Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Camptothecin-d5

Camptothecin-d5 is the deuterium labeled Camptothecin. Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM[1]. Camptothecin (CPT) exhibits powerful antineoplastic activity against colorectal, breast, lung and ovarian cancers, modulates hypoxia-inducible factor-1α (HIF-1α) activity by changing microRNAs (miRNA) expression patterns in human cancer cells[2][3].

Product Specifications

CAS Number

1329616-37-6

Product Name Alternative

Campathecin-d5; (S) - (+) -Camptothecin-d5; CPT-d5

UNSPSC

12352005

Target

ADC Payload; Antibiotic; Apoptosis; Fungal; Influenza Virus; Isotope-Labeled Compounds; MicroRNA; Topoisomerase

Type

Isotope-Labeled Compounds

Related Pathways

Antibody-drug Conjugate/ADC Related; Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Others

Field of Research

Cancer; Infection

Purity

99.61

Solubility

10 mM in DMSO

Smiles

[2H]C([2H])([2H])C([2H])([2H])[C@@]1(C2=C(COC1=O)C(N3C(C4=NC5=CC=CC=C5C=C4C3)=C2)=O)O

Molecular Formula

C20H11D5N2O4

Molecular Weight

353.38

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Luzzio MJ, et al. Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I. Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I.|[3]Bertozzi D, et al. The natural inhibitor of DNA topoisomerase I, camptothecin, modulates HIF-1α activity by changing miR expression patterns in human cancer cells. Mol Cancer Ther. 2014;13 (1) :239-248.|[4]Schön M, et al. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment. J Natl Cancer Inst. 2008;100 (12) :862-875..|[5]Huang Q, et al. Evolution in medicinal chemistry of E-ring-modified Camptothecin analogs as anticancer agents. Eur J Med Chem. 2013;63:746-757.|[6]Tesauro C, et al. Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study. BMC Cancer. 2019;19 (1) :1158. Published 2019 Nov 29.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, protect from light, stored under nitrogen)

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

HOXB4 Antibody
MBS8580673-01 0.1 mL

HOXB4 Antibody

Sign In for Pricing
View Details
HOXB4 Antibody
MBS8580673-02 0.1 mL (AF635)

HOXB4 Antibody

Sign In for Pricing
View Details
HOXB4 Antibody
MBS8580673-03 0.1 mL (AF610)

HOXB4 Antibody

Sign In for Pricing
View Details
HOXB4 Antibody
MBS8580673-04 0.1 mL (AF405S)

HOXB4 Antibody

Sign In for Pricing
View Details
HOXB4 Antibody
MBS8580673-05 0.1 mL (AF405L)

HOXB4 Antibody

Sign In for Pricing
View Details
HOXB4 Antibody
MBS8580673-06 0.1 mL (AF546)

HOXB4 Antibody

Sign In for Pricing
View Details